Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2019-11-12 5:30 pm Sale | 13G | MERUS N V COM MRUS | BIOTECHNOLOGY VALUE FUND L P | 3,343,413 11.6% | -1,171,500 (-25.95%) | View |
2019-11-08 5:17 pm Purchase | 13G | FIVE PRIME THERAPEUTICS INC FPRX | BIOTECHNOLOGY VALUE FUND L P | 5,967,119 16.4% | 1,823,228 (+44.00%) | View |
2019-10-28 5:25 pm Purchase | 13G | PRINCIPIA BIOPHARMA INC PRNB | BIOTECHNOLOGY VALUE FUND L P | 1,636,850 5% | 1,636,850 (New Position) | View |
2019-10-09 5:30 pm Purchase | 13G | MERSANA THERAPEUTICS INC MRSN | BIOTECHNOLOGY VALUE FUND L P | 4,926,419 10.3% | 2,426,419 (+97.06%) | View |
2019-10-02 4:42 pm Purchase | 13G | FIVE PRIME THERAPEUTICS INC FPRX | BIOTECHNOLOGY VALUE FUND L P | 4,143,891 11.3% | 1,362,545 (+48.99%) | View |
2019-09-23 5:12 pm Purchase | 13G | SPRINGWORKS THERAPEUTICS INC C SWTX | BIOTECHNOLOGY VALUE FUND L P | 2,843,845 6.6% | 2,843,845 (New Position) | View |
2019-09-16 5:16 pm Purchase | 13G | AC IMMUNE SA SHS ACIU | BIOTECHNOLOGY VALUE FUND L P | 11,297,911 16.7% | 3,842,377 (+51.54%) | View |
2019-09-09 4:44 pm Purchase | 13G | GLYCOMIMETICS INC GLYC | BIOTECHNOLOGY VALUE FUND L P | 7,361,801 17% | 2,925,000 (+65.93%) | View |
2019-08-15 1:09 pm Purchase | 13G | GLYCOMIMETICS INC GLYC | BIOTECHNOLOGY VALUE FUND L P | 4,436,801 10.3% | 3,939,327 (+791.87%) | View |
2019-08-07 4:56 pm Purchase | 13G | CORVUS PHARMACEUTICALS INC CRVS | BIOTECHNOLOGY VALUE FUND L P | 3,032,850 10.3% | 1,142,343 (+60.43%) | View |
2019-07-03 3:31 pm Sale | 13G | CONCERT PHARMACEUTICALS INC CO CNCE | BIOTECHNOLOGY VALUE FUND L P | 1,408,187 5.9% | -1,377,300 (-49.45%) | View |
2019-06-27 6:06 pm Purchase | 13G | ESSA PHARMA INC EPIX | BIOTECHNOLOGY VALUE FUND L P | 1,329,700 16.7% | 749,333 (+129.11%) | View |
2019-06-25 4:49 pm Purchase | 13G | CALITHERA BIOSCIENCES INC CALA | BIOTECHNOLOGY VALUE FUND L P | 6,750,482 13.1% | 3,452,200 (+104.67%) | View |
2019-06-07 4:20 pm Purchase | 13G | IDEAYA BIOSCIENCES INC IDYA | BIOTECHNOLOGY VALUE FUND L P | 1,505,429 7.4% | 1,505,429 (New Position) | View |
2019-05-20 5:22 pm Purchase | 13G | VERASTEM, INC. VSTM | BIOTECHNOLOGY VALUE FUND L P | 5,512,994 7.5% | 1,999,000 (+56.89%) | View |
2019-05-10 4:24 pm Purchase | 13G | NOVUS THERAPEUTICS INC NVUS | BIOTECHNOLOGY VALUE FUND L P | 1,336,556 9.99% | 1,336,556 (New Position) | View |
2019-04-26 4:45 pm Sale | 13D | ONCOMED PHARMACEUTICALS INC CO OMED | BIOTECHNOLOGY VALUE FUND L P | 0 0% | -4,042,989 (Position Closed) | View |